The 10 remaining mysteries of inflammatory bowel disease

Colombel, Jean-Frédéric; Watson, Alastair J. M.; Neurath, Markus F.
April 2008
Gut;Apr2008, Vol. 57 Issue 4, p429
Academic Journal
Question & Answer
The article presents questions and answers related to inflammatory bowel disease (IBD) including the historical variation in the incidence of IBD, the factors in determining the initial attack of IBD and subsequent relapses, and the role of extraluminal structures in Crohn's disease (CD).


Related Articles

  • Clinical - Top 50 - Inflammatory bowel disease.  // GP: General Practitioner;12/23/2005, p26 

    The article focuses on the symptoms and diagnosis of inflammatory bowel disease (IBD). IBD refers to both ulcerative colitis (UC) and Crohn's disease. These are chronic inflammatory disorders of the GI tract characterised by relapses and remissions. Both also manifest outside the gut. Prompt...

  • Can Calprotectin Predict Relapse Risk in Inflammatory Bowel Disease? D'Inc, Renata; Dal Pont, Elisabetta; Di Leo, Vincenza; Benazzato, Luca; Martinato, Matteo; Lamboglia, Francesca; Oliva, Lydia; Carlo Sturniolo, Giacomo // American Journal of Gastroenterology;Aug2008, Vol. 103 Issue 8, p2007 

    OBJECTIVE: Assessing the clinical course of inflammatory bowel disease (IBD) patients consists of periodical clinical evaluations and laboratory tests. We aimed to assess the role of calprotectin tests in predicting clinical relapse in IBD patients. METHODS: Ninety-seven patients with ulcerative...

  • Pathogenesis of postoperative recurrence in Crohn's disease. Tasneem Ahmed // Gut;Apr2011, Vol. 60 Issue 4, p553 

    The majority of patients with Crohn's disease (CD) require surgery during the course of their disease, but such surgery is typically not curative. Although some studies suggest that the disease state is theoretically reset to its earliest phase following surgery, disease phenotype and natural...

  • Inflammatory Bowel Disorders.  // Current Medical Literature: Gastroenterology;2011, Vol. 30 Issue 1, p21 

    The article discusses various research that explored the different aspects of inflammatory bowel disorders. One of the studies dealt with the changes in surgical resection rates and medical treatments for Crohn's disease. Another research focused on the association of pre-operative management...

  • Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis. Thomas, Saskia; Baumgart, Daniel // Inflammopharmacology;Feb2012, Vol. 20 Issue 1, p1 

    Crohn's disease and ulcerative colitis are two chronic inflammatory bowel diseases. Current biologic therapies are limited to blocking tumor necrosis factor alpha. However, some patients are primary non-responders, experience a loss of response, intolerance or side effects defining the urgent...

  • Information management and informatics: need for a modern pathology service. Jones, Rick; O'Connor, John // Annals of Clinical Biochemistry;May2004, Vol. 41 Issue 3, p183 

    Requirements for information technology in pathology now extend well beyond the provision of purely analytical data. With the aim of achieving seamless integration of laboratory data into the total clinical pathway, 'informatics' - the art and science of turning data into useful information - is...

  • New therapeutic approach in inflammatory bowel disease. PAPA, A.; MOCCI, G.; SCALDAFERRI, F.; BONIZZI, M.; FELICE, C.; ANDRISANI, G.; GASBARRINI, A. // European Review for Medical & Pharmacological Sciences;Jan2009 Supplement, Vol. 13 Issue S-1, p33 

    In the last decade, biologic agents, in particular infliximab and adalimumab, have deeply changed the therapeutic armamentarium of inflammatory bowel disease (IBD). However, these drugs have a number of contraindications and side-effects that physicians should know so to avoid and eventually...

  • Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Viget, N.; Vernier-Massouille, G.; Salmon-Ceron, D.; Yazdanpanah, Y.; Colombel, J.-F. // Gut;Apr2008, Vol. 57 Issue 4, p549 

    Because of the increasing use of immunosuppressive and biological drugs, the occurrence of opportunistic infections has become a key safety issue for patients with inflammatory bowel disease (IBD). Consequently, improvement of healthcare workers' knowledge of this domain is urgent. In this...

  • Lamina Propria and Circulating Interleukin-8 in Newly and Previously Diagnosed Pediatric Inflammatory Bowel Disease Patients. Krishna Reddy; Eduardo Ruchelli // Digestive Diseases & Sciences;Feb2007, Vol. 52 Issue 2, p365 

    Abstract??Dysregulation of interleukin-8 (IL-8) production has been proposed to contribute to intestinal inflammation in inflammatory bowel disease (IBD) patients. Previous studies, which evaluate adult patients with long-standing or steroid-modulated disease, have reported conflicting results...


Read the Article


Sign out of this library

Other Topics